BioCentury
ARTICLE | Financial News

EpiTan to list on AIM

March 31, 2005 2:55 AM UTC

EpiTan (ASX:EPT) plans to list on LSE's AIM and to raise up to L15 million ($28 million). Teather & Greenwood is adviser and broker. The proceeds will be used to fund development of Melanotan, a synth...